Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Convalescent plasma for people with COVID-19: a living systematic review
Claire Iannizzi, Khai Li Chai, Vanessa Piechotta, et al.
Cochrane library (2023) Vol. 2024, Iss. 2
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Convalescent plasma and predictors of mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis
Massimo Franchini, Mario Cruciani, Carlo Mengoli, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1514-1522
Closed Access | Times Cited: 8
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trial
Simone Hoffmann, Eva Schrezenmeier, Maxime Desmarets, et al.
EBioMedicine (2025) Vol. 113, pp. 105613-105613
Open Access
Exploring the potential of Claude 2 for risk of bias assessment: Using a large language model to assess randomized controlled trials with RoB 2
Angelika Eisele‐Metzger, Judith-Lisa Lieberum, Markus Toews, et al.
Research Synthesis Methods (2025), pp. 1-18
Open Access
Antiplatelet agents for the treatment of adults with COVID-19
Anna-Lena Fischer, Sarah Messer, Rachel Riera, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 9
Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
Life (2024) Vol. 14, Iss. 2, pp. 214-214
Open Access | Times Cited: 2
Extension of the PRISMA 2020 statement for living systematic reviews (PRISMA-LSR): checklist and explanation
Elie A. Akl, Joanne Khabsa, Claire Iannizzi, et al.
BMJ (2024), pp. e079183-e079183
Open Access | Times Cited: 2
Experiences in the use of multiple doses of convalescent plasma in critically ill patients with COVID‐19: An early phase 1 descriptive study
Ricardo Aguilar, Sandra López‐Vergès, Anarellys Quintana, et al.
Health Science Reports (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 1
Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients
Massimo Franchini, Carlo Mengoli, Arturo Casadevall, et al.
Life (2024) Vol. 14, Iss. 7, pp. 792-792
Open Access | Times Cited: 1
Reduction in ACE2 expression in peripheral blood mononuclear cells during COVID-19 – implications for post COVID-19 conditions
Gulrayz Ahmed, Yasir Abdelgadir, Amro Abdelghani, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Exome and genome sequencing for rare genetic disease diagnosis: A scoping review and critical appraisal of clinical guidance documents produced by genetics professional organizations
Taila Hartley, Meredith Gillespie, Ian D. Graham, et al.
Genetics in Medicine (2023) Vol. 25, Iss. 11, pp. 100948-100948
Open Access | Times Cited: 4
Hyperimmune Plasma and Immunoglobulins Against COVID-19: A Narrative Review
Massimo Franchini, Daniele Focosi
(2023)
Open Access | Times Cited: 4
Passive antibody therapy in emerging infectious diseases
Xiaoming Yang
Frontiers of Medicine (2023) Vol. 17, Iss. 6, pp. 1117-1134
Closed Access | Times Cited: 3
Is there any revival of the use of plasma therapy or neutralizing convalescent antibody therapy to treat SARS-CoV-2 variants and are we rethinking preparedness plans?
Olivier Garraud, Hervé Watier
Transfusion and Apheresis Science (2023) Vol. 62, Iss. 3, pp. 103726-103726
Open Access | Times Cited: 2
Design of VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1): A double-blind, randomized placebo-controlled trial of COVID-19 convalescent plasma in hospitalized patients with early respiratory compromise
Edward N. Janoff, Sheldon T. Brown, Ilana Belitskaya‐Lévy, et al.
Contemporary Clinical Trials Communications (2023) Vol. 35, pp. 101190-101190
Open Access | Times Cited: 2
Immunological sub-phenotypes and response to Convalescent Plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial.
Benoît Misset, Anh Nguyet Diep, Axelle Bertrand, et al.
Research Square (Research Square) (2024)
Open Access
Experience report of two living systematic Cochrane reviews on COVID-19
Carina Wagner, Caroline Hirsch, Waldemar Siemens, et al.
Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen (2024) Vol. 184, pp. 90-95
Open Access
Convalescent Plasma for Critically-ill Covid-19 Patients
Adel A. Aljatham, Waleed T. Hashim, Mohamad A. Almashiakhi, et al.
Research Square (Research Square) (2024)
Open Access
Insights and innovations in Blood Transfusion.
Serelina Coluzzi, L Mascaretti
PubMed (2024) Vol. 22, Iss. 4, pp. 277-278
Closed Access
The effect of convalescent plasma therapy on the rate of nucleic acid negative conversion in patients with persistent COVID-19 test positivity
Yixuan Wang, Zhe Xu, Xue Xu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
What are the clinical and research lessons learned from immunomodulators and other therapies during the COVID-19 pandemic?
Daniel A. Sweeney, Pedro Póvoa
Current Opinion in Critical Care (2024) Vol. 30, Iss. 5, pp. 420-426
Closed Access
The role of convalescent plasma and hyperimmune immunoglobulins in the COVID-19 pandemic, including implications for future preparedness
Cynthia So‐Osman, Thierry Burnouf, Arwa Z. Al‐Riyami, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Biochemical rationale for transfusion of high titre COVID-19 convalescent plasma
Caro Verbrugghe, Elise Wouters, Rosalie Devloo, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Immunological sub-phenotypes and response to convalescent plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial
Benoît Misset, Anh Nguyet Diep, Axelle Bertrand, et al.
Annals of Intensive Care (2024) Vol. 14, Iss. 1
Open Access
CONVALESCENT PLASMA THERAPY FOR COVID-19 – DONOR SELECTION STRATEGIES AND ESTABLISHMENT OF A PLASMA BANK
Mikael Kajova, Tamim Khawaja, Iris Levonen, et al.
New Microbes and New Infections (2024) Vol. 62, pp. 101525-101525
Open Access
Use of convalescent plasma in COVID-19 treatment: is clinical severity more important than the intervention?
Valéria de Freitas Dutra, Heitor Duarte de Andrade, Viviane Regina Hernandez Nunes, et al.
Einstein (São Paulo) (2024) Vol. 22
Open Access
Page 1 - Next Page

Scroll to top